Our Seminar Series - Upcoming & Historic
The CRUK Manchester Institute seminar series engages world-class researchers across the broad spectrum of cancer research and runs alongside a series of themed seminar programmes in the MCRC, The Christie and across the University of Manchester.
Our Seminar Series - Upcoming & Historic
The CRUK Manchester Institute seminar series engages world-class researchers across the broad spectrum of cancer research and runs alongside a series of themed seminar programmes in the MCRC, The Christie and across the University of Manchester.
Oglesby Lecture Theatre
Irmela Jeremias – Therapeutic Targeting of Functionally Diverse Leukemia Stem Cells
21st January 2025. 14:00

Irmela Jeremias is Head of the “Research Unit Apoptosis in Hematopoietic Stem Cells” at Helmholtz Munich. She is a Pediatrician interested in improving treatment of children with acute leukemias.
Host: Georges Lacaud
Speaker: Irmela Jeremias
Oglesby Lecture Theatre
Filipe Pereira – In Vivo Dendritic Cell Reprogramming for Cancer Immunotherapy
28th January 2025. 14:00

Filipe Pereira is a Professor of Molecular Medicine in the Faculty of Medicine at Lund University in Sweden. He is recognised for his work at the interface of cellular reprogramming and immunology and for fostering development of reprogramming-based immunotherapies.
Host: Georges Lacaud
Speaker: Filipe Pereira
Oglesby Lecture Theatre
John Haanen – Learnings from TIL in melanoma for next gen cell therapies
11th February 2025. 14:00

John Haanen is a Group Leader at the NKI focussing on Cancer immunotherapy. The goal of his research is to find biomarkers that help select patients that are likely to respond to immune checkpoint inhibitors and develop novel strategies for cell therapy.
Host: Mark Williams
Speaker: John Haanen
Oglesby Lecture Theatre
Daniel Tennant – Proline metabolism and the tumour microenvironment – essential lessons from a non-essential amino acid
25th February 2025. 14:00

Professor Daniel Tennant is a Professor of Biochemistry in the Department of Metabolism and Systems Science. He uses stable isotope tracers to investigate changes in the use of nutrients in conditions where oxygen is limiting (hypoxia), or in the presence of genetic mutations that induce a hypoxia-like response.
Host: Kathryn Simpson
Speaker: Daniel Tennant
Oglesby Lecture Theatre
Gioacchino Natoli
4th March 2025. 14:00

Gioacchino Natoli is a Group Leader in the Department of Experimental Oncology at the European Institute of Oncology. His primary scientific interests are in cell biology, transcription factors, genetics, regulation of gene expression and chromatin.
Host: Claus Jørgensen
Speaker: Gioacchino Natoli
Oglesby Lecture Theatre
Trevor Graham
25th March 2025. 14:00

Trevor Graham is Director of the Centre for Evolution and Cancer at the ICR leads the Genomics and Evolutionary Dynamics laboratory. His research is focused on understanding the evolutionary dynamics of cancer development and translating this knowledge to improve clinical management of disease.
Host: Claus Jørgensen
Speaker: Trevor Graham
Our Research
Our research spans the whole spectrum of cancer research from cell biology through to translational and clinical studies
Research Groups
Our research groups study many fundamental questions of cancer biology and treatment
Our Facilities
The Institute has outstanding core facilities that offer cutting edge instruments and tailored services from expert staff
Latest News & Updates
Find out all our latest news
Careers that have a lasting impact on cancer research and patient care
We are always on the lookout for talented and motivated people to join us. Whether your background is in biological or chemical sciences, mathematics or finance, computer science or logistics, use the links below to see roles across the Institute in our core facilities, operations teams, research groups, and studentships within our exceptional graduate programme.